Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 20, 2021

SELL
$86.23 - $125.19 $45,701 - $66,350
-530 Closed
0 $0
Q4 2020

Jan 29, 2021

BUY
$79.17 - $111.47 $41,960 - $59,079
530 New
530 $47,000
Q2 2019

Aug 09, 2019

SELL
$39.92 - $53.86 $172,973 - $233,375
-4,333 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$48.23 - $66.16 $1,012 - $1,389
21 Added 0.49%
4,333 $219,000
Q4 2018

Feb 14, 2019

BUY
$55.63 - $73.24 $239,876 - $315,810
4,312 New
4,312 $256,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $442M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Fortem Financial Group, LLC Portfolio

Follow Fortem Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortem Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortem Financial Group, LLC with notifications on news.